サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1537019

PET放射性トレーサー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年

PET Radioactive Tracers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 359 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
PET放射性トレーサー市場：世界の産業分析、規模、シェア、成長、動向、予測、2024年～2033年
出版日: 2024年08月09日
発行: Persistence Market Research
ページ情報: 英文 359 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Researchはこのほど、世界のPET放射性トレーサー市場に関する包括的なレポートを発表しました。この詳細な分析は、促進要因、動向、機会、課題を含む市場力学に関する重要な洞察を提供し、市場構造の完全な理解を提供します。

主要な洞察

  • PET放射性トレーサー市場規模（2024年）：10億5,390万米ドル
  • 市場予測金額（2033年）：19億2,630万米ドル
  • 世界市場成長率（CAGR 2024年～2033年）：6.9%

PET放射性トレーサー市場：調査範囲

PET放射性トレーサー市場は、ポジトロン断層撮影（PET）イメージングで様々な疾患の検出やモニタリングに利用される様々な製品をカバーしています。この市場には、フルオロデオキシグルコース（FDG）、アンモニア、コリンなど、正確な画像診断に不可欠なさまざまな種類のPET放射性トレーサーが含まれます。同市場は、病院、画像診断センター、研究機関など多様なセグメントに対応しており、直販、オンラインプラットフォーム、医療用品販売代理店などのチャネルを通じて流通しています。画像技術の進歩、慢性疾患の増加、疾患の早期発見と個別化医療に対する需要の高まりが成長の促進力となっています。

市場成長の促進要因：

世界のPET放射性トレーサー市場の成長にはいくつかの要因が寄与しています。PETイメージングと放射性トレーサー開発における技術進歩は、診断能力と精度を向上させます。がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加は、早期診断と治療モニタリングのためのPETイメージング需要を促進します。さらに、個別化医療と精密診断への注目の高まりが、PET放射性トレーサーの採用を後押ししています。ヘルスケアインフラや研究開発への投資の増加も市場拡大を後押ししています。

市場抑制要因：

PET放射性トレーサー市場は成長の可能性があるにもかかわらず、PETイメージングと放射性トレーサーのコストが高いという課題に直面しています。規制上の制約や放射性物質に対する厳しい安全基準が、市場運営を複雑にしています。さらに、PET画像処理には専門的なインフラと訓練を受けた人材が必要であることも市場に影響を与えています。代替イメージング技術との競合や分子イメージングの進歩も、市場成長の課題となる可能性があります。これらの問題に対処するには、コスト削減、規制遵守、継続的な技術革新に注力する必要があります。

市場機会：

PET放射性トレーサー市場は、精密医療のトレンドの高まりとイメージング技術の進歩により、大きなビジネスチャンスをもたらしています。診断能力を強化した新しい放射性トレーサーの市場開拓は、市場拡大の可能性を秘めています。慢性疾患の増加や高齢化により、PETイメージングサービスの需要が増加しています。新興市場への進出、遠隔医療と遠隔診断の成長により、新たな成長の道が開けます。戦略的パートナーシップ、研究開発への投資、革新的なトレーサー製剤の採用は、新たな機会を活用し、市場でのリーダーシップを維持するために不可欠です。

本レポートで扱う主要な質問

  • PET放射性トレーサー市場の世界の成長を促進する主要な要因は何か？
  • PET放射性トレーサーのどの種類と用途が、様々な診断現場で採用されているか？
  • 技術進歩はPET放射性トレーサー市場の競合情勢にどのような影響を与えているか？
  • PET放射性トレーサー市場の主要企業はどこで、競争力を維持するためにどのような戦略を採用しているのか？
  • 世界のPET放射性トレーサー市場の新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲 / 分類
  • 市場の定義 / 範囲 / 制限
  • 包含事項・除外事項

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • イノベーション / 開発動向

第4章 主要な成功要因

  • PETスキャナのインストールベースシナリオ
  • PETスキャン数：国別
  • 疾病疫学
  • 製品の採用 / 使用状況分析
  • 規制承認の経路
  • 払い戻しシナリオ
  • 技術の進歩
  • 適正製造規範（cGMP）
  • バリューチェーン分析
  • 品質基準/認定
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因 - 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • 2024年の市場シナリオ
  • COVID-19と影響分析
    • 製品別
    • 用途別
    • エンドユーザー別
    • 地域別

第7章 世界市場の需要（金額または規模、百万米ドル）分析

  • 過去の市場金額（百万米ドル）分析、2019年～2023年
  • 現在および将来の市場金額（百万米ドル）予測、2024年～2033年
    • 前年比成長動向分析
    • 絶対額の機会分析

第8章 世界市場分析：製品別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：製品別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）分析と予測：製品別、2024年～2033年
    • F-18
    • C-11
    • Ga-68
    • O-15
    • N-13
    • Cu-64
  • 市場の魅力分析：エンドユーザー別

第9章 世界市場分析：用途別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：用途別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：用途別、2024年～2033年
    • 神経疾患
    • がんの診断と予後
    • 心臓機能障害
    • 感染症の診断
    • その他
  • 市場の魅力分析：用途別

第10章 世界市場分析：エンドユーザー別

  • イントロダクション / 主要な調査結果
  • 過去の市場規模（百万米ドル）の分析：エンドユーザー別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：エンドユーザー別、2024年～2033年
    • 病院
    • 専門診断センター
    • がん研究センター
    • 学術調査機関
  • 市場の魅力分析：エンドユーザー別

第11章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（百万米ドル）の分析：地域別、2019年～2023年
  • 現在および将来の市場規模（百万米ドル）の分析と予測：地域別、2024年～2033年
    • 北米
    • ラテンアメリカ
    • 東アジア
    • 南アジア・太平洋
    • 西欧
    • 東欧
    • 中央アジア
    • ロシア・ベラルーシ
    • バルカン半島・バルト諸国
    • 中東・アフリカ
  • 市場の魅力分析：地域別

第12章 北米市場分析

第13章 ラテンアメリカ市場分析

第14章 東アジア市場分析

第15章 南アジア・太平洋市場分析

第16章 西欧市場分析

第17章 東欧市場分析

第18章 中央アジア市場分析

第19章 ロシア・ベラルーシ市場分析

第20章 バルカン半島・バルト諸国市場分析

第21章 中東・アフリカ（MEA）市場分析

第22章 市場構造分析

  • 市場分析：企業階層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第23章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細情報
    • Eli Lilly and Company
    • Blue Earth Diagnostics
    • Lantheus
    • Siemens Healthcare Private Limited
    • GE Healthcare
    • Advanced Accelerator Applications（Novartis）
    • University of Lowa HealthCare
    • Telix Pharmaceuticals Limited
    • Jubilant Radiopharma
    • TRASIS
    • RadioMedix Inc.
    • IBA Radiopharma Solutions
    • Piramal Imaging（Life Molecular Imaging）
    • Cardinal Health
    • DuchemBio, Co., Ltd

第24章 使用される前提条件と頭字語

第25章 調査手法

目次
Product Code: PMRREP33446

Persistence Market Research has recently released a comprehensive report on the global PET Radioactive Tracers Market. This detailed analysis provides critical insights into the market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

  • PET Radioactive Tracers Market Size (2024E): USD 1,053.9 Million
  • Projected Market Value (2033F): USD 1,926.30 Million
  • Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

PET Radioactive Tracers Market - Report Scope:

The PET Radioactive Tracers Market covers a range of products utilized in positron emission tomography (PET) imaging to detect and monitor various diseases. This market includes different types of PET radioactive tracers, such as fluorodeoxyglucose (FDG), ammonia, and choline, essential for accurate diagnostic imaging. The market caters to diverse segments including hospitals, diagnostic imaging centers, and research institutions, distributed through channels like direct sales, online platforms, and medical supply distributors. Growth is driven by advancements in imaging technology, increasing prevalence of chronic diseases, and rising demand for early disease detection and personalized medicine.

Market Growth Drivers:

Several factors contribute to the growth of the global PET Radioactive Tracers Market. Technological advancements in PET imaging and radioactive tracer development enhance diagnostic capabilities and accuracy. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions drives the demand for PET imaging for early diagnosis and treatment monitoring. Furthermore, the rising focus on personalized medicine and precision diagnostics boosts the adoption of PET radioactive tracers. Increased investments in healthcare infrastructure and research and development also fuel market expansion.

Market Restraints:

Despite its growth potential, the PET Radioactive Tracers Market faces challenges related to the high cost of PET imaging and radioactive tracers, which can limit their accessibility and adoption. Regulatory constraints and stringent safety standards for radioactive materials add complexity to market operations. Additionally, the market is impacted by the need for specialized infrastructure and trained personnel for PET imaging procedures. Competition from alternative imaging techniques and advancements in molecular imaging may also pose challenges to market growth. Addressing these issues requires a focus on cost reduction, regulatory compliance, and ongoing innovation.

Market Opportunities:

The PET Radioactive Tracers Market presents significant opportunities driven by the growing trend of precision medicine and advancements in imaging technologies. The development of new and improved radioactive tracers with enhanced diagnostic capabilities offers potential for market expansion. The rising prevalence of chronic diseases and an aging population increase the demand for PET imaging services. Expansion into emerging markets and the growth of telemedicine and remote diagnostics present new avenues for growth. Strategic partnerships, investments in R&D, and the introduction of innovative tracer formulations are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PET Radioactive Tracers Market globally?
  • Which types and applications of PET radioactive tracers are leading the adoption in various diagnostic settings?
  • How are technological advancements influencing the competitive landscape of the PET Radioactive Tracers Market?
  • Who are the key players in the PET Radioactive Tracers Market, and what strategies are they employing to stay competitive?
  • What are the emerging trends and future prospects in the global PET Radioactive Tracers Market?

Competitive Intelligence and Business Strategy:

Leading players in the global PET Radioactive Tracers Market, including GE Healthcare, Siemens Healthineers, and Philips Healthcare, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced radioactive tracers and imaging technologies, such as PET-CT and PET-MRI systems. Collaborations with research institutions, hospitals, and diagnostic centers facilitate market access and promote new product adoption. Emphasis on regulatory compliance, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving PET Radioactive Tracers Market landscape.

Key Companies Profiled:

  • Eli Lilly and Company
  • Blue Earth Diagnostics
  • Lantheus
  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Advanced Accelerator Applications (Novartis)
  • University of Lowa HealthCare
  • Telix Pharmaceuticals Limited
  • Jubilant Radiopharma
  • TRASIS
  • RadioMedix Inc.
  • IBA Radiopharma Solutions
  • Piramal Imaging (Life Molecular Imaging)
  • Cardinal Health
  • DuchemBio, Co. Ltd.

PET Radioactive Tracers Market Industry Segmentation

By Product Type:

  • F-18
  • C-11
  • Ga-68
  • O-15
  • N-13
  • Cu-64

By Applications

  • Neurological Disorders
  • Cancer Diagnosis & Prognosis
  • Cardiac Dysfunctions
  • Infectious Disease Diagnosis
  • Others

By End User:

  • Hospitals
  • Speciality Diagnostic Centers
  • Cancer Research Centers
  • Academic & Research Institutes

By Region:

  • North America
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Western Europe
  • Eastern Europe
  • Central Asia
  • Russia & Belarus
  • Balkan & Baltic Countries
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Innovation / Development Trends

4. Key Success Factors

  • 4.1. PET Scanner Installed Base Scenario
  • 4.2. Number of PET Scans, By Country
  • 4.3. Disease Epidemiology
  • 4.4. Product Adoption/Usage Analysis
  • 4.5. Regulatory Approval Pathway
  • 4.6. Reimbursement Scenario
  • 4.7. Technology Advancements
  • 4.8. Good Manufacturing Practice (cGMP)
  • 4.9. Value Chain Analysis
  • 4.10. Quality Standards/Accreditations
  • 4.11. PESTEL Analysis
  • 4.12. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Oncology Spending
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Development of Novel Products
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Targeted Therapies
    • 5.2.4. Increasing Prevalence of Cancer
    • 5.2.5. Strategic Mergers and Acquisitions among Local Players
    • 5.2.6. Rising Awareness towards Development of Disease
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Region

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
    • 8.3.1. F-18
      • 8.3.1.1. Florbetapir
      • 8.3.1.2. Florbetaben
      • 8.3.1.3. Flutemetamol
      • 8.3.1.4. Fludeoxyglucose
      • 8.3.1.5. Sodium Fluoride
      • 8.3.1.6. Others
    • 8.3.2. C-11
      • 8.3.2.1. Choline
      • 8.3.2.2. Methionine
      • 8.3.2.3. Others
    • 8.3.3. Ga-68
      • 8.3.3.1. DOTA-TOC
      • 8.3.3.2. DOTATATE
      • 8.3.3.3. DOTANOC
      • 8.3.3.4. Others
    • 8.3.4. O-15
    • 8.3.5. N-13
    • 8.3.6. Cu-64
  • 8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
    • 9.3.1. Neurological Disorders
      • 9.3.1.1. Alzheimer's Disease
      • 9.3.1.2. Dementia
      • 9.3.1.3. Others
    • 9.3.2. Cancer Diagnosis & Prognosis
      • 9.3.2.1. Solid Tumor
      • 9.3.2.2. Hematology Tumor
    • 9.3.3. Cardiac Dysfunctions
      • 9.3.3.1. Myocardial Infarction
      • 9.3.3.2. Others
    • 9.3.4. Infectious disease Diagnosis
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Speciality Diagnostic Centers
    • 10.3.3. Cancer Research Centers
    • 10.3.4. Academic & Research Institutes
  • 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. East Asia
    • 11.3.4. South Asia & Pacific
    • 11.3.5. Western Europe
    • 11.3.6. Eastern Europe
    • 11.3.7. Central Asia
    • 11.3.8. Russia & Belarus
    • 11.3.9. Balkan & Baltic Countries
    • 11.3.10. Middle East & Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Country
      • 12.3.1.1. U.S.
      • 12.3.1.2. Canada
    • 12.3.2. By Product
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Country
    • 12.4.2. By Product
    • 12.4.3. By Application
    • 12.4.4. By End User
  • 12.5. Key Market Trends
  • 12.6. Drivers and Restraints - Impact Analysis
  • 12.7. Key Players - Intensity Mapping
  • 12.8. Country Level Analysis & Forecast
    • 12.8.1. U.S. Market
      • 12.8.1.1. Introduction
      • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.1.2.1. By Product
        • 12.8.1.2.2. By Application
        • 12.8.1.2.3. By End User
    • 12.8.2. Canada Market
      • 12.8.2.1. Introduction
      • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 12.8.2.2.1. By Product
        • 12.8.2.2.2. By Application
        • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. Brazil
      • 13.3.1.2. Argentina
      • 13.3.1.3. Mexico
      • 13.3.1.4. Rest of Latin America
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By End User
  • 13.5. Key Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. Brazil Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
        • 13.8.1.2.3. By End User
    • 13.8.2. Argentina Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application
        • 13.8.2.2.3. By End User
    • 13.8.3. Mexico Market
      • 13.8.3.1. Introduction
      • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.3.2.1. By Product
        • 13.8.3.2.2. By Application
        • 13.8.3.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product
    • 14.3.3. By Application
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By End User
  • 14.5. Key Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. China Market
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By End User
    • 14.8.2. Japan Market
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By End User
    • 14.8.3. South Korea Market
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By End User

15. South Asia & Pacific Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. India
      • 15.3.1.2. Indonesia
      • 15.3.1.3. Thailand
      • 15.3.1.4. Philippines
      • 15.3.1.5. Malaysia
      • 15.3.1.6. Vietnam
      • 15.3.1.7. Rest of ASEAN
      • 15.3.1.8. Australia & New Zealand
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By End User
  • 15.5. Key Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. India Market
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By End User
    • 15.8.2. Indonesia Market
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By End User
    • 15.8.3. Thailand Market
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By End User
    • 15.8.4. Philippines Market
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By End User
    • 15.8.5. Malaysia Market
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Application
        • 15.8.5.2.3. By End User
    • 15.8.6. Vietnam Market
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Application
        • 15.8.6.2.3. By End User
    • 15.8.7. Australia & New Zealand Market
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Application
        • 15.8.7.2.3. By End User

16. Western Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. France
      • 16.3.1.3. Spain
      • 16.3.1.4. Italy
      • 16.3.1.5. BENELUX
      • 16.3.1.6. Nordic Countries
      • 16.3.1.7. United Kingdom
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By End User
  • 16.5. Key Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. Germany Market
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By End User
    • 16.8.2. France Market
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By End User
    • 16.8.3. Spain Market
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By End User
    • 16.8.4. Italy Market
      • 16.8.4.1. Introduction
      • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.4.2.1. By Product
        • 16.8.4.2.2. By Application
        • 16.8.4.2.3. By End User
    • 16.8.5. BENULUX Market
      • 16.8.5.1. Introduction
      • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.5.2.1. By Product
        • 16.8.5.2.2. By Application
        • 16.8.5.2.3. By End User
    • 16.8.6. Nordic Countries Market
      • 16.8.6.1. Introduction
      • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.6.2.1. By Product
        • 16.8.6.2.2. By Application
        • 16.8.6.2.3. By End User
    • 16.8.7. U.K. Market
      • 16.8.7.1. Introduction
      • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.7.2.1. By Product
        • 16.8.7.2.2. By Application
        • 16.8.7.2.3. By End User

17. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. Poland
      • 17.3.1.2. Hungary
      • 17.3.1.3. Romania
      • 17.3.1.4. Czech Republic
      • 17.3.1.5. Rest of Eastern Europe
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By End User
  • 17.5. Key Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. Poland Market
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By End User
    • 17.8.2. Hungary Market
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By End User
    • 17.8.3. Romania Market
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
        • 17.8.3.2.3. By End User
    • 17.8.4. Czech Republic Market
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application
        • 17.8.4.2.3. By End User

18. Central Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 18.3.1. By Product
    • 18.3.2. By Application
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Product
    • 18.4.2. By Application
    • 18.4.3. By End User
  • 18.5. Key Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping

19. Russia & Belarus Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 19.3.1. By Product
    • 19.3.2. By Application
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Product
    • 19.4.2. By Application
    • 19.4.3. By End User
  • 19.5. Key Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping

20. Balkan & Baltic Countries Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 20.3.1. By Product
    • 20.3.2. By Application
    • 20.3.3. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Product
    • 20.4.2. By Application
    • 20.4.3. By End User
  • 20.5. Key Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Key Players - Intensity Mapping

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 21.1. Introduction
  • 21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
    • 21.3.1. By Country
      • 21.3.1.1. GCC Countries
      • 21.3.1.2. Kingdom of Saudi Arabia
      • 21.3.1.3. Turkiye
      • 21.3.1.4. Northern Africa
      • 21.3.1.5. South Africa
      • 21.3.1.6. Israel
    • 21.3.2. By Product
    • 21.3.3. By Application
    • 21.3.4. By End User
  • 21.4. Market Attractiveness Analysis
    • 21.4.1. By Country
    • 21.4.2. By Product
    • 21.4.3. By Application
    • 21.4.4. By End User
  • 21.5. Key Market Trends
  • 21.6. Drivers and Restraints - Impact Analysis
  • 21.7. Key Players - Intensity Mapping
  • 21.8. Country Level Analysis & Forecast
    • 21.8.1. GCC Countries Market
      • 21.8.1.1. Introduction
      • 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.1.2.1. By Product
        • 21.8.1.2.2. By Application
        • 21.8.1.2.3. By End User
    • 21.8.2. Kingdom of Saudi Arabia Market
      • 21.8.2.1. Introduction
      • 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.2.2.1. By Product
        • 21.8.2.2.2. By Application
        • 21.8.2.2.3. By End User
    • 21.8.3. Turkiye Market
      • 21.8.3.1. Introduction
      • 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.3.2.1. By Product
        • 21.8.3.2.2. By Application
        • 21.8.3.2.3. By End User
    • 21.8.4. Northern Africa Market
      • 21.8.4.1. Introduction
      • 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.4.2.1. By Product
        • 21.8.4.2.2. By Application
        • 21.8.4.2.3. By End User
    • 21.8.5. South Africa Market
      • 21.8.5.1. Introduction
      • 21.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.5.2.1. By Product
        • 21.8.5.2.2. By Application
        • 21.8.5.2.3. By End User
    • 21.8.6. Israel Market
      • 21.8.6.1. Introduction
      • 21.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 21.8.6.2.1. By Product
        • 21.8.6.2.2. By Application
        • 21.8.6.2.3. By End User

22. Market Structure Analysis

  • 22.1. Market Analysis by Tier of Companies
  • 22.2. Market Share Analysis of Top Players
  • 22.3. Market Presence Analysis
    • 22.3.1. Regional footprint of Players
    • 22.3.2. Platform Type foot print by Players
    • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

  • 23.1. Competition Dashboard
  • 23.2. Competition Benchmarking
  • 23.3. Competition Deep Dive
    • 23.3.1. Eli Lilly and Company
      • 23.3.1.1. Company Overview
      • 23.3.1.2. Product Portfolio
      • 23.3.1.3. Sales Footprint
      • 23.3.1.4. Key Financials
      • 23.3.1.5. SWOT Analysis
      • 23.3.1.6. Key Developments
      • 23.3.1.7. Strategy Overview
        • 23.3.1.7.1. Channel Strategy
        • 23.3.1.7.2. Marketing Strategy
        • 23.3.1.7.3. Product Strategy
    • 23.3.2. Blue Earth Diagnostics
      • 23.3.2.1. Company Overview
      • 23.3.2.2. Product Portfolio
      • 23.3.2.3. Sales Footprint
      • 23.3.2.4. Key Financials
      • 23.3.2.5. SWOT Analysis
      • 23.3.2.6. Key Developments
      • 23.3.2.7. Strategy Overview
        • 23.3.2.7.1. Channel Strategy
        • 23.3.2.7.2. Marketing Strategy
        • 23.3.2.7.3. Product Strategy
    • 23.3.3. Lantheus
      • 23.3.3.1. Company Overview
      • 23.3.3.2. Product Portfolio
      • 23.3.3.3. Sales Footprint
      • 23.3.3.4. Key Financials
      • 23.3.3.5. SWOT Analysis
      • 23.3.3.6. Key Developments
      • 23.3.3.7. Strategy Overview
        • 23.3.3.7.1. Channel Strategy
        • 23.3.3.7.2. Marketing Strategy
        • 23.3.3.7.3. Product Strategy
    • 23.3.4. Siemens Healthcare Private Limited
      • 23.3.4.1. Company Overview
      • 23.3.4.2. Product Portfolio
      • 23.3.4.3. Sales Footprint
      • 23.3.4.4. Key Financials
      • 23.3.4.5. SWOT Analysis
      • 23.3.4.6. Key Developments
      • 23.3.4.7. Strategy Overview
        • 23.3.4.7.1. Channel Strategy
        • 23.3.4.7.2. Marketing Strategy
        • 23.3.4.7.3. Product Strategy
    • 23.3.5. GE Healthcare
      • 23.3.5.1. Company Overview
      • 23.3.5.2. Product Portfolio
      • 23.3.5.3. Sales Footprint
      • 23.3.5.4. Key Financials
      • 23.3.5.5. SWOT Analysis
      • 23.3.5.6. Key Developments
      • 23.3.5.7. Strategy Overview
        • 23.3.5.7.1. Channel Strategy
        • 23.3.5.7.2. Marketing Strategy
        • 23.3.5.7.3. Product Strategy
    • 23.3.6. Advanced Accelerator Applications (Novartis)
      • 23.3.6.1. Company Overview
      • 23.3.6.2. Product Portfolio
      • 23.3.6.3. Sales Footprint
      • 23.3.6.4. Key Financials
      • 23.3.6.5. SWOT Analysis
      • 23.3.6.6. Key Developments
      • 23.3.6.7. Strategy Overview
        • 23.3.6.7.1. Channel Strategy
        • 23.3.6.7.2. Marketing Strategy
        • 23.3.6.7.3. Product Strategy
    • 23.3.7. University of Lowa HealthCare
      • 23.3.7.1. Company Overview
      • 23.3.7.2. Product Portfolio
      • 23.3.7.3. Sales Footprint
      • 23.3.7.4. Key Financials
      • 23.3.7.5. SWOT Analysis
      • 23.3.7.6. Key Developments
      • 23.3.7.7. Strategy Overview
        • 23.3.7.7.1. Channel Strategy
        • 23.3.7.7.2. Marketing Strategy
        • 23.3.7.7.3. Product Strategy
    • 23.3.8. Telix Pharmaceuticals Limited
      • 23.3.8.1. Company Overview
      • 23.3.8.2. Product Portfolio
      • 23.3.8.3. Sales Footprint
      • 23.3.8.4. Key Financials
      • 23.3.8.5. SWOT Analysis
      • 23.3.8.6. Key Developments
      • 23.3.8.7. Strategy Overview
        • 23.3.8.7.1. Channel Strategy
        • 23.3.8.7.2. Marketing Strategy
        • 23.3.8.7.3. Product Strategy
    • 23.3.9. Jubilant Radiopharma
      • 23.3.9.1. Company Overview
      • 23.3.9.2. Product Portfolio
      • 23.3.9.3. Sales Footprint
      • 23.3.9.4. Key Financials
      • 23.3.9.5. SWOT Analysis
      • 23.3.9.6. Key Developments
      • 23.3.9.7. Strategy Overview
        • 23.3.9.7.1. Channel Strategy
        • 23.3.9.7.2. Marketing Strategy
        • 23.3.9.7.3. Product Strategy
    • 23.3.10. TRASIS
      • 23.3.10.1. Company Overview
      • 23.3.10.2. Product Portfolio
      • 23.3.10.3. Sales Footprint
      • 23.3.10.4. Key Financials
      • 23.3.10.5. SWOT Analysis
      • 23.3.10.6. Key Developments
      • 23.3.10.7. Strategy Overview
        • 23.3.10.7.1. Channel Strategy
        • 23.3.10.7.2. Marketing Strategy
        • 23.3.10.7.3. Product Strategy
    • 23.3.11. RadioMedix Inc.
      • 23.3.11.1. Company Overview
      • 23.3.11.2. Product Portfolio
      • 23.3.11.3. Sales Footprint
      • 23.3.11.4. Key Financials
      • 23.3.11.5. SWOT Analysis
      • 23.3.11.6. Key Developments
      • 23.3.11.7. Strategy Overview
        • 23.3.11.7.1. Channel Strategy
        • 23.3.11.7.2. Marketing Strategy
        • 23.3.11.7.3. Product Strategy
    • 23.3.12. IBA Radiopharma Solutions
      • 23.3.12.1. Company Overview
      • 23.3.12.2. Product Portfolio
      • 23.3.12.3. Sales Footprint
      • 23.3.12.4. Key Financials
      • 23.3.12.5. SWOT Analysis
      • 23.3.12.6. Key Developments
      • 23.3.12.7. Strategy Overview
        • 23.3.12.7.1. Channel Strategy
        • 23.3.12.7.2. Marketing Strategy
        • 23.3.12.7.3. Product Strategy
    • 23.3.13. Piramal Imaging (Life Molecular Imaging)
      • 23.3.13.1. Company Overview
      • 23.3.13.2. Product Portfolio
      • 23.3.13.3. Sales Footprint
      • 23.3.13.4. Key Financials
      • 23.3.13.5. SWOT Analysis
      • 23.3.13.6. Key Developments
      • 23.3.13.7. Strategy Overview
        • 23.3.13.7.1. Channel Strategy
        • 23.3.13.7.2. Marketing Strategy
        • 23.3.13.7.3. Product Strategy
    • 23.3.14. Cardinal Health
      • 23.3.14.1. Company Overview
      • 23.3.14.2. Product Portfolio
      • 23.3.14.3. Sales Footprint
      • 23.3.14.4. Key Financials
      • 23.3.14.5. SWOT Analysis
      • 23.3.14.6. Key Developments
      • 23.3.14.7. Strategy Overview
        • 23.3.14.7.1. Channel Strategy
        • 23.3.14.7.2. Marketing Strategy
        • 23.3.14.7.3. Product Strategy
    • 23.3.15. DuchemBio, Co., Ltd
      • 23.3.15.1. Company Overview
      • 23.3.15.2. Product Portfolio
      • 23.3.15.3. Sales Footprint
      • 23.3.15.4. Key Financials
      • 23.3.15.5. SWOT Analysis
      • 23.3.15.6. Key Developments
      • 23.3.15.7. Strategy Overview
        • 23.3.15.7.1. Channel Strategy
        • 23.3.15.7.2. Marketing Strategy
        • 23.3.15.7.3. Product Strategy

24. Assumptions and Acronyms Used

25. Research Methodology